Screener
Recursion Pharmaceuticals, Inc. RXRX Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
FAQ
- What is Recursion Pharmaceuticals, Inc.'s gross profit?
- Recursion Pharmaceuticals, Inc. (RXRX) reported gross profit of -$3.82M in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s gross profit changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s gross profit decreased by 307.4% year-over-year, from -$938K to -$3.82M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s gross profit?
- Over 2 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s gross profit has grown at a -39.5% compound annual growth rate (CAGR), from $10.18M to $3.73M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Recursion Pharmaceuticals, Inc.'s gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude